Play all audios:
Access through your institution Buy or subscribe Midwood, K. _ et al_. TenascinC is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in
arthritis joint disease. _Nat. Med._ 15, 774–780 (2009). After more than a decade of studying tenascin C, Kim Midwood and colleagues have discovered a role for this extracellular matrix
protein as an endogenous ligand for Toll-like receptor (TLR) 4 that mediates persistent synovial inflammation in arthritic joint disease. This is a preview of subscription content, access
via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy
this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: *
Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support Authors * Katrin Legg View author publications You can also search for this author inPubMed Google
Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Legg, K. Tenascin C: a candidate for chronic inflammation?. _Nat Rev Rheumatol_ 5, 469 (2009).
https://doi.org/10.1038/nrrheum.2009.132 Download citation * Issue Date: September 2009 * DOI: https://doi.org/10.1038/nrrheum.2009.132 SHARE THIS ARTICLE Anyone you share the following link
with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt
content-sharing initiative